Coming soon: Glaucoma self-care, from home?

September 23, 2017 by Amy Norton, Healthday Reporter

(HealthDay)—For many glaucoma patients, repeat trips to a doctor's office to check on their eyes can be a real pain.

But new research supports the usefulness of a device that allows patients to measure their own eye pressure—in the comfort of their own home.

Researchers found that among 100 glaucoma patients, most were able to successfully use the handheld device, called Icare HOME. That suggests that at-home measurements would be reasonable for many, the study authors said.

Glaucoma refers to a group of diseases where fluid builds up in the eye, creating pressure that damages the . It's a leading cause of blindness in older adults, according to the American Academy of Ophthalmology.

Many people are familiar with the tests eye doctors use to detect and monitor glaucoma, including tonometry, which measures pressure within the eye. Doctors do it with an instrument that puts a small amount of pressure on the cornea using a tiny probe or puff of air.

The problem is, pressure within the eye shifts throughout the day, said Dr. Andrew Tatham, the lead researcher on the new study.

That means periodic office measurements may not tell the whole story, said Tatham, a consultant ophthalmologist at the University of Edinburgh in Scotland.

So Tatham's team decided to study a home device that is designed for "self-tonometry."

Icare HOME, developed by a Finnish company, is already on the market. It was approved in the United States earlier this year. Tatham and his colleagues wanted to find out how easily patients can use the product.

With funding from the UK's National Health Service, the researchers recruited 100 patients with either glaucoma or ocular hypertension—higher-than-normal pressure in the eye that can lead to glaucoma.

Each patient received a 30-minute lesson on using the home tonometer, then the investigators watched as the patient tried it out. The patients' self-measurements were then compared against an eye doctor's measurements—using standard office testing—and the researchers' measurements using the home device.

Just under three-quarters of the patients met with success, the study found. The patients used the tonometer correctly and got readings within 5 points of what the professionals did with the same device.

A few others were able to take self-measurements, but ended up with readings that were more than 5 points off. The rest—one-fifth of the group—were unable to manage the device.

The findings suggest that many glaucoma patients can manage the device, at least right after being shown how.

But that does not mean people need one, said Dr. Andrew Iwach, a spokesperson for the American Academy of Ophthalmology. He was not involved in the research.

He said the concept of home tonometry is "a good one," and could prove useful in certain circumstances.

But should patients rush out to buy one of these? "No," Iwach said.

In theory, Tatham explained, home measurements could help doctors better monitor glaucoma patients, and know when treatment is necessary—or whether a current treatment is working well.

Treatment—including eye-drop medications and laser surgery—can help prevent further damage to the optic nerve and ward off vision loss.

But, Iwach said, eye pressure measurements are only "one piece of the puzzle." And doctors and patients will have to consider whether the burden of home measurements is worthwhile on a case-by-case basis.

"I think for most patients, our current techniques do the trick," Iwach said.

How does the home tonometer work? Users hold it over one eye, and a green light tells them when it's properly positioned. The device then sends out a tiny probe that "gently touches" the cornea for a few milliseconds, Tatham said.

There's no need for the numbing eye drops that doctors use for office measurements. In this study, Tatham said, most patients said the was "comfortable to use."

But the most important question, he said, is whether home measurements will make a difference in patients' risk of vision loss.

"Studies are needed that examine whether having more measurements from self-tonometry improves our ability to identify at higher risk of visual loss," Tatham said.

What's important, Iwach noted, is that adults get a "baseline" eye exam at age 40, and return for follow-ups as their doctor suggests.

"The good news," he said, "is that when we catch glaucoma early enough, we can help you maintain your vision."

The study results were published online recently in JAMA Ophthalmology.

Explore further: Self-tonometry feasible, acceptable for glaucoma patients

More information: Andrew Tatham, FRCOphth., consultant ophthalmologist, University of Edinburgh, Scotland; Andrew Iwach, M.D., clinical spokesperson, American Academy of Ophthalmology, San Francisco, and executive director, Glaucoma Center of San Francisco; Aug. 31, 2017, JAMA Ophthalmology, online

The American Academy of Ophthalmology has more on glaucoma.

Related Stories

Self-tonometry feasible, acceptable for glaucoma patients

September 4, 2017
(HealthDay)—For patients with glaucoma, self-tonometry is feasible and acceptable to patients, according to a study published online Aug. 31 in JAMA Ophthalmology.

GAT values more discordant than DCT measures in glaucoma

May 17, 2017
(HealthDay)—Conventional Goldmann applanation tonometry (GAT) values for intraocular pressure (IOP) are significantly discordant compared with Pascal dynamic contour tonometry (DCT) measurements in patients with thin corneas ...

Home measurement of eye pressure in children may improve management of glaucoma

March 7, 2012
Measurement of pressure within the eye, or intraocular pressure (IOP), is known to fluctuate throughout the day, and wide swings in patients with glaucoma are believed to be related to the progression of the disease, which ...

New device could save glaucoma patients' eyesight

December 6, 2016
People with high-risk glaucoma will be able to monitor their disease, anywhere, anytime, thanks to a new device developed by an FIU professor.

Timed-release glaucoma drug insert shows promise as alternative to daily drops

May 5, 2016
A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops. New research shows a medicated silicone ...

ECP, second drainage device effective in refractory glaucoma

September 1, 2016
(HealthDay)—For patients with refractory glaucoma with failed initial tube shunt, both endoscopic cyclophotocoagulation (ECP) and implantation of a second glaucoma drainage device (GDD-2) are effective as second surgeries, ...

Recommended for you

Newly published research provides new insight into how diabetes leads to retinopathy

December 7, 2017
An international team of scientists led by Professor Ingrid Fleming of Goethe University, Frankfurt, Germany, and including Professor Bruce Hammock of the University of California, Davis, provides new insight into the mechanism ...

Researchers use breakthrough technology to understand eclipse eye damage

December 7, 2017
In a first-of-its-kind study, Mount Sinai researchers are using adaptive optics (AO) to analyze retinal eye damage from the August solar eclipse on a cellular level. The research could help doctors develop a deeper understanding ...

Combating eye injuries with a reversible superglue seal

December 6, 2017
When a soldier sustains a traumatic eye injury on the battlefield, any delay in treatment may lead to permanent vision loss. With medical facilities potentially far away and no existing tools to prevent deterioration, medics ...

Trigger for most common form of vision loss discovered

November 27, 2017
In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the ...

Scientists engineer drug delivery device that treats glaucoma directly inside the eye

November 23, 2017
Glaucoma, which affects over 60 million people worldwide, can seem easy to treat: medicated eye drops can be used to ease the buildup of fluid in the eye that underlies the condition. If glaucoma is caught early, eye drops ...

Research reveals biological mechanism of a leading cause of childhood blindness

November 16, 2017
Scientists at the Virginia Tech Carilion Research Institute (VTCRI) have revealed the pathology of cells and structures stricken by optic nerve hypoplasia, a leading cause of childhood blindness in developed nations.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.